Application of sapindus mukorossi Gaertn. in preparing drug for resisting paralembus digitiformis

A technology of Sapindus scutellaria and Sapindus scutellaria, which is applied in the field of application of Sapindus scutellaria in the preparation of anti-scutellaria medicaments, and can solve problems such as the inability to determine the effect of anti-scutellum ciliates

Inactive Publication Date: 2019-08-23
BEIJING CENT BIOLOGY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The effect of Sapindus on the shield ciliate of turbot has not been reported yet, and based on the existing data of Sapindus, it is impossible to conclude that it has the effect of resisting the shield ciliate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of sapindus mukorossi Gaertn. in preparing drug for resisting paralembus digitiformis
  • Application of sapindus mukorossi Gaertn. in preparing drug for resisting paralembus digitiformis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1 Preparation of Sapindaceae powder: take 100 g of Sapindaceae medicinal material, add 20 g of anti-caking agent, pulverize, and pass through a 200-mesh sieve.

[0017] The usage and dosage of the powder: mix the above 100g powder into 100kg feed, and feed according to the daily food intake.

Embodiment 2

[0018] Example 2 Preparation of Sapindus chinensis liquid preparation: Take 200 g of Sapindia chinensis medicinal material, add 10 times the amount of food-grade ethanol, heat at 70° C., soak and extract, and finally concentrate to 500 ml.

[0019] Dosage of the alcoholic extract of Sapindus chinensis: take 500ml of the alcoholic extract of Sapindus chinensis, and pour it into 1000kg of seawater, and perform a medicated bath for turbot suffering from scutellaria ciliates.

[0020] The following will illustrate the anti-shield ciliate effect of Sapindus in combination with specific experiments.

[0021] One, observe the drug effect of embodiment 2 to the prevention and treatment of turbot shield ciliate disease.

[0022] Construction of turbot challenge model: The scutellum ciliate larvae in the exponential growth phase were used for the challenge. Use iron gauze to rub the back muscle of turbot (about 200g) with an abrasion area of ​​2cm×2cm, add worms at a rate of about 5000...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of sapindus mukorossi Gaertn. in preparing a drug for resisting paralembus digitiformis, and belongs to the technical field of medicine. The sapindus mukorossi Gaertn. can be prepared into powder with any acceptable auxiliary material, then the powder is added into feed, and then scophthalmus maximus suffering from paralembus digitiformis diseases is fed with the feed; or the sapindus mukorossi Gaertn. is subjected to ethanol extraction, the auxiliary material is added to prepare liquid, and then the scophthalmus maximus suffering from paralembus digitiformis diseases is subjected to a medicated bath. According to the application of the sapindus mukorossi Gaertn. in preparing the drug for resisting the paralembus digitiformis, it is found for the first time that the sapindus mukorossi Gaertn. can significantly lower the death rate of the paralembus digitiformis diseases of the scophthalmus maximus, and the infection rate of the paralembus digitiformis is lowered.

Description

technical field [0001] The invention belongs to the technical field of medicine. The invention relates to a new application of a traditional Chinese medicinal material, in particular to the application of Sapindus chinensis in the preparation of anti-ciliate ciliates. Background technique [0002] Turbot (Scophthalmus maximus), also known as turbot, is naturally distributed in the European coast from the east of the Atlantic Ocean to the northeast, where it lives as a bottom dweller. Since it was introduced into our country, it has created good economic benefits, and its artificial breeding has become one of the important pillar industries of marine aquaculture in our country. However, as the breeding density of turbot continues to increase and the research on disease control lags behind, various breeding diseases are coming one after another. Among various aquaculture diseases, parasitic diseases caused by scutellaria, Cryptocaryonia, Trichodinia or flagellates etc. have ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/77A61P33/02A23K10/30A23K50/80
CPCA61K36/77A23K10/30A23K50/80A61P33/02
Inventor 李福元侯晓礁陈立红马培倩秦俊杰吕慧源郭智伟李学良郑运和王秀敏江厚生王顺山韩俊国梁伟王保山
Owner BEIJING CENT BIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap